Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_assertion type Assertion NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_head.
- NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_assertion description "[Compared with control brain, HIV-1 Tg rat brain showed immunoreactivity to glycoprotein 120 and tat HIV-1 viral proteins, and significantly higher protein and mRNA levels of (1) the inflammatory cytokines interleukin-1? and tumor necrosis factor ?, (2) the activated microglial/macrophage marker CD11b, (3) AA cascade enzymes: AA-selective Ca2+-dependent cytosolic phospholipase A2 (cPLA2)-IVA, secretory sPLA2-IIA, cyclooxygenase (COX)-2, membrane prostaglandin E2 synthase, 5-lipoxygenase (LOX) and 15-LOX, cytochrome p450 epoxygenase, and (4) transcription factor NF-?Bp50 DNA binding activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_provenance.
- NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_assertion evidence source_evidence_literature NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_provenance.
- NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_assertion SIO_000772 21846384 NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_provenance.
- NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_assertion wasDerivedFrom befree-2016 NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_provenance.
- NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_assertion wasGeneratedBy ECO_0000203 NP917390.RALt_ZYxsnfpeaiJdw1JF8EaSjX8CzLCguG9ku_d1sS_I130_provenance.